Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (281-290 of 1,622) with videos related to

Pageof 163
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Interactions between academic oncology and alternative/complementary/integrative medicine: complex but necessaryM Markman
Expert Review of Anticancer Therapy|July 13, 2002
Intraperitoneal chemotherapy in the management of malignant diseaseM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Cancer genetic risk assessment: a note of cautionM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapyM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Why does a higher response rate to chemotherapy correlate poorly with improved survival?M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the 24th annual meeting of the Society of Gynecologic Oncologists, February 7-10, 1993M Markman
Current Opinion in Obstetrics & Gynecology|February 1, 1993
Current status of intraperitoneal therapy for ovarian cancerM Markman
Journal of the American Dental Association (1939)|October 30, 2020
More on Disruptive InnovationsStanley Markman
Exploration of Targeted Anti-Tumor Therapy|January 26, 2026
The critical need for robust decision support in the era of precision cancer therapeuticsMaurie Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The administration of paclitaxel without prophylaxis for the prevention of hypersensitivity reactions: is this a rationale and safe therapeutic strategy?M Markman
Pageof 163

Showing results (281-290 of 1,622) with videos related to

Sort By:
Pageof 163
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Interactions between academic oncology and alternative/complementary/integrative medicine: complex but necessaryM Markman
Expert Review of Anticancer Therapy|July 13, 2002
Intraperitoneal chemotherapy in the management of malignant diseaseM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Cancer genetic risk assessment: a note of cautionM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapyM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Why does a higher response rate to chemotherapy correlate poorly with improved survival?M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the 24th annual meeting of the Society of Gynecologic Oncologists, February 7-10, 1993M Markman
Current Opinion in Obstetrics & Gynecology|February 1, 1993
Current status of intraperitoneal therapy for ovarian cancerM Markman
Journal of the American Dental Association (1939)|October 30, 2020
More on Disruptive InnovationsStanley Markman
Exploration of Targeted Anti-Tumor Therapy|January 26, 2026
The critical need for robust decision support in the era of precision cancer therapeuticsMaurie Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The administration of paclitaxel without prophylaxis for the prevention of hypersensitivity reactions: is this a rationale and safe therapeutic strategy?M Markman
Pageof 163